Wordt geladen...
CYP17 inhibitors for prostate cancer therapy
Prostate cancer (PC) is now the second most prevalent cause of death in men in the USA and Europe. At present, the major treatment options include surgical or medical castration. These strategies cause ablation of the production of testosterone (T), dihydrotestosterone (DHT) and related androgens by...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047603/ https://ncbi.nlm.nih.gov/pubmed/21092758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsbmb.2010.11.005 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|